WILMINGTON, N.C. — Christine Dingivan, a former executive at biologics firm MedImmune, is the new chief medical officer at Pharmaceutical Product Development (Nasdaq: PPDI).
Dingivan succeeds Paul Covington, who retired June 30. Covington had served as CMO since 2002.
Dingivan, a physician, will lead PPD, a global contract research organization, in assessment of medical data and set strategic direction for global regulatory affairs, pharmacovigilance, biomarker discovery services and other areas.
A graduate of Dartmouth Medical School, she also earned a degree in bioengineering at the University of Pennsylvania.
PPD names former MedImmune exec as chief medical officer
Copyright 2008 by WRAL.com. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
-
- UNC spin-off receives $2 million grant for cancer treatment technology
Sep. 5, 2008 - Sting and Tool to rock in new Guitar Hero® World Tour
Sep. 5, 2008 - Biotechnology Center Summer Workshops a success
Sep. 5, 2008 - rPath launches technology to accelerate adoption of cloud computing
Sep. 5, 2008 - The ad about nothing: Seinfeld and Gates go shoe shopping
Sep. 5, 2008
- UNC spin-off receives $2 million grant for cancer treatment technology
-
- ChannelAdvisor announces $20 million in new funding
Sep. 5, 2008 - Rho brings multi-million dollar federal contract to RTP
Sep. 4, 2008 - Senator Richard Burr to speak at NCTA’s National Leaders Symposium
Sep. 4, 2008 - Cary-based BrightDoor raises $2 million in first round
Sep. 4, 2008 - NSF Grant furthers Geomagic’s work in product design, development
Sep. 3, 2008
- ChannelAdvisor announces $20 million in new funding
More from wrallocaltechwire.com
Market Watch

